Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Spironolactone in Adolescents with PCOS
NCT03981861Phase 3Completed
- Sponsor
- Children's Mercy Kansas City
- Start
- Jul 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of liquid metformin (Aspargo Labs) and spironolactone in polycystic ovary syndrome (PCOS), sponsored by Children's Mercy Kansas City. Primary endpoints: Oral Glucose Tolerance Test at 6 Months, Total Testosterone at 6 Months and 3 more. Started Jul 2016; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)spironolactone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03981861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03981861.